Figure (Logo)
Lyumjev Injection, Solution
Product Images NDC 0002-8351
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Lyumjev (NDC 0002-8351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Lyumjev Clock V1)
An illustration of a stopwatch or timer displaying a five-second duration, with the timer hand pointing to the 5-second mark in a shaded segment. This image likely indicates a timing instruction related to the product's use.*
Figure (Lyumjev Inj Sites V1)
An instructional diagram showing recommended injection sites for LYUMJEV (insulin lispro-aabc) injection, solution. The front view highlights the abdomen and the front of both thighs as injection areas, while the back view shows the upper outer arms and the buttocks as additional injection sites.*
Figure (Lyumjev Needle Tab V1)
An instructional illustration showing a hand holding a cap on a vial, with an arrow indicating the cap being lifted or removed. The image depicts how to open the vial cap, related to the preparation of an injectable solution.*
Figure (Lyumjev Pen Attach Needle V1)
An instructional illustration showing the removal of a tube cap by peeling off a protective seal or cover, represented by a red arrow indicating the direction of removal. The image likely relates to preparation or usage steps for the injection solution tube or vial.*
Figure (Lyumjev Pen Remove Needle V1)
An instructional illustration showing a hand holding an insulin pen injection device with a dose selector dial wrapped by a red ribbon or film, indicating a step or technique related to the device's use for injection.*
Figure (Lyumjev Pen Remove Shield V1)
An instructional diagram showing removal of a cap from a vial. The image illustrates that the vial cap should be kept while the inner seal or stopper is to be thrown away, indicated by directional arrows and labeled components.*
Figure (Lyumjev Pen Replace Shield V1)
An instructional illustration showing a hand holding a syringe with a needle cap being removed, indicated by an orange arrow pointing away from the syringe's tip. This image likely demonstrates the step to remove the needle cap before injection.*
Figure (Lyumjev Pen Tap V1)
An instructional illustration showing a hand holding a syringe with the other hand flicking or tapping the syringe barrel, presumably to remove air bubbles before injection. The image is related to the administration of LYUMJEV (insulin lispro-aabc) injection, solution.*
Figure (Lyumjev Pen Uncap V1)
An illustration showing the proper removal of a needle cap from a syringe or injection pen. The needle cap is being pulled straight off in the direction of an arrow pointing left, demonstrating safe needle preparation for administration.*
Qr Code (Lyumjev Qr V1)
Lyumjev U100 Cartridge 022 00
LYUMJEV (insulin lispro-aabc) injection 100 units per mL (U-100) in a 5 x 3 mL cartridge package. The label includes branding for Eli Lilly and Company, dosage form as injection for subcutaneous use, and a caution note stating "For Single Patient Use Only." Storage instructions, dosage reference, and a drug composition summary with inactive ingredients are also shown.*
Figure (Lyumjev U100 Jrkp Ifu F1 V1)
LYUMJEV Junior KwikPen injection, a prefilled pen device for insulin lispro-aabc with a dosage strength of 100 units per mL. The pen is designed for subcutaneous or intravenous administration and labeled for single patient use. The labeler is Eli Lilly and Company.*
Figure (Lyumjev U100 Jrkp Ifu F10 V1)
An instructional illustration showing a person injecting a solution into their abdominal area using a syringe. The image highlights the proper injection technique for a subcutaneous route, typically associated with insulin products such as LYUMJEV insulin lispro-aabc injection solution.*
Figure (Lyumjev U100 Jrkp Ifu F11 V1)
An instructional illustration showing the removal of a cap clip from an injection pen. The image highlights the cap clip with a label and an arrow indicating the direction to pull the pen from the cap clip. The illustration is simple and uses a side view of the injection pen and the cap clip.*
Figure (Lyumjev U100 Jrkp Ifu F2 V1)
Illustration showing parts of the LYUMJEV Junior KwikPen insulin injection device, including the pen cap with cap clip, cartridge holder with rubber seal, plunger, pen body with label, and dose indicator featuring a dose window and dose knob.*
Figure (Lyumjev U100 Jrkp Ifu F3 V1)
An instructional illustration showing the parts of a pen needle for injection, including the outer needle shield, inner needle shield, needle, and paper tab, along with an image of a dose knob. The diagram specifies that needles are not included.*
Figure (Lyumjev U100 Jrkp Ifu F4 V1)
An instructional illustration showing a part of a syringe or injector with a dosage window displaying units, accompanied by a red upward-pointing arrow, presumably indicating dosage adjustment or injection technique.*
Figure (Lyumjev U100 Jrkp Ifu F5 V1)
An instructional illustration showing hands holding a syringe filled with liquid. A close-up inset highlights a detail on the syringe plunger, and a large red arrow points upward from the bottom of the syringe, indicating a step or movement to be performed. This image likely depicts a procedural step in preparing or using an injectable solution.*
Figure (Lyumjev U100 Jrkp Ifu F6 V1)
The image shows a close-up view of a portion of a vial or cartridge of LYUMJEV insulin lispro-aabc injection, solution. The vial has visible measurement markings for dose volume, ranging from 0 to 0.5 mL, with numeric labels. The background includes a peach or light orange-colored component, possibly part of the vial or packaging. The image focuses on the dosing scale without showing product branding or detailed label text.*
Figure (Lyumjev U100 Jrkp Ifu F7 V1)
An instructional diagram showing a close-up of a dosing dial on an insulin pen with visible dose markings. A red arrow points away from the dial, likely indicating how to operate or adjust the dose setting on the pen. The image relates to the use of insulin injection devices such as LYUMJEV (insulin lispro-aabc).*
Figure (Lyumjev U100 Jrkp Ifu F8 V1)
An illustration showing a close-up view of a grey injection pen with a visible dose window displaying numbers 3, 4, and 5. A red indicator line points to the number 5. The pen features a peach-colored dose button on the right side, indicating a dosing mechanism for precise insulin administration.*
Figure (Lyumjev U100 Jrkp Ifu F9 V1)
An instructional diagram showing a close-up view of a pen device dose window. It displays a numeric dose scale from 0 to 11 with an arrow indicator pointing at dose 11, used to select or confirm the administered dose volume in units.*
Package Label – Lyumjev U100 Junior Kwikpen 5 Count Carton (Lyumjev U100 Jrkp Nl110 00)
LYUMJEV Junior KwikPen insulin lispro-aabc injection 100 units per mL (U-100) carton label. The box indicates it is a subcutaneous injection for single patient use only, containing 5 prefilled pens of 3 mL each. Labeler is Eli Lilly and Company. The label includes storage, dosage instructions, and a caution to contact pharmacist if seal is broken before first use.*
Package Label – Lyumjev U100 Kwikpen 5 Count Carton (Lyumjev U100 Kp 053 00)
LYUMJEV KwikPen 100 units per mL (U-100) injection with active ingredient insulin lispro-aabc, presented in 5 prefilled pens of 3 mL each. For subcutaneous use only, labeled for single patient use. The carton is marked with Eli Lilly and Company as the labeler and provides storage, dosage, and contact information, along with a National Drug Code (NDC). The pen device is not included with needles and recommended for use with specified insulin pen needles.*
Figure (Lyumjev U100 Kp Ifu F1 V1)
LYUMJEV 100 units/mL injection in a KwikPen autoinjector device. The pen is dark gray with a white label displaying the proprietary and generic names, dosing instructions, and usage restriction for single patient use. The pen cap is removed and placed beside the device. The labeler is Eli Lilly and Company.*
Figure (Lyumjev U100 Kp Ifu F10 V1)
An instructional illustration showing a person injecting an insulin solution subcutaneously into the abdomen. The image depicts the hand holding a syringe or pen device at a 90-degree angle to the skin at the abdominal area, demonstrating proper injection technique for insulin.*
Figure (Lyumjev U100 Kp Ifu F11 V1)
An instructional diagram showing the removal of a cap clip from a syringe-like device for LYUMJEV (insulin lispro-aabc) injection solution. The image includes an arrow indicating direction and a label pointing to the cap clip component.*
Figure (Lyumjev U100 Kp Ifu F2 V1)
An illustration diagram showing the parts of the LYUMJEV KwikPen insulin lispro-aabc injection pen. Labeled components include the Pen Cap with Cap Clip, Rubber Seal, Cartridge Holder, Plunger, Pen Body with Label, Dose Indicator with Dose Window, and Dose Knob.*
Figure (Lyumjev U100 Kp Ifu F3 V1)
Illustration showing parts of a pen needle for injection, including an outer needle shield, inner needle shield, needle, and paper tab. Also shown separately is a blue dose knob, typically used for adjusting dosage on a medication pen device.*
Figure (Lyumjev U100 Kp Ifu F4 V1)
An instructional illustration showing a close-up of a syringe cartridge with measurement markings (0, 1, 2, 4) visible. A red arrow points upward from the cartridge to a dark blue plunger, indicating the direction to pull or push the plunger within the syringe for dose measurement or administration.*
Figure (Lyumjev U100 Kp Ifu F5 V1)
An instructional diagram showing a hand holding a syringe or injection pen with a zoomed-in view of the tip or needle area, illustrating proper handling or injection steps for a medication delivery device.*
Figure (Lyumjev U100 Kp Ifu F6 V1)
Packaging label of LYUMJEV 200 units per milliliter injection, solution by Eli Lilly and Company. The image shows a portion of the label on a cartridge or pen with a numeric display reading '100', indicating the strength of 200 IU/mL insulin lispro-aabc for intravenous or subcutaneous use.*
Figure (Lyumjev U100 Kp Ifu F7 V1)
An instructional illustration showing a hand removing a blue cap from a syringe or pen device. An orange arrow points upward, indicating the direction to pull the cap off. The device appears to have measurement markings visible on the side.*
Figure (Lyumjev U100 Kp Ifu F8 V1)
Illustration showing a close-up view of a container with a label partially revealed under a sliding cover, with a red arrow pointing to the number '12' on the label. The image appears to highlight a detail on the container's label.*
Figure (Lyumjev U100 Kp Ifu F9 V1)
An instructional diagram showing a close-up view of a syringe scale with numerical markings from 2 to 26. A red indicator line points to a precise measurement, likely demonstrating dose calibration or administration technique for an injection device.*
Figure (Lyumjev U100 Tp Ifu F1 V1)
LYUMJEV Tempo Pen insulin lispro-aabc injection pen, designed for subcutaneous or intravenous administration. The pen displays the product name, concentration options including 100 units per mL (U-100), and indicates it is for single patient use only. The labeler shown is Eli Lilly and Company. The pen is gray with a dark blue removable cap.*
Figure (Lyumjev U100 Tp Ifu F10 V1)
An instructional illustration showing a person administering an injection using a syringe. The syringe is being inserted into the abdomen area just above the waistband, demonstrating the subcutaneous injection technique.*
Figure (Lyumjev U100 Tp Ifu F11 V1)
An instructional diagram showing the removal of a cap clip from a syringe or pen injector. The image highlights the cap clip component with an arrow indicating the direction to pull it off before use.*
Figure (Lyumjev U100 Tp Ifu F2 V1)
An illustration labeled 'LYUMJEV Tempo Pen Parts' showing the components of a Tempo pen injection device. Parts identified include the Pen Cap with Cap Clip, Rubber Seal, Cartridge Holder, Plunger, Pen Body labeled with product name and strength, Dose Indicator, Dose Window, and Dose Knob, arranged in an exploded view from left to right.*
Figure (Lyumjev U100 Tp Ifu F3 V1)
An illustration showing parts of a pen needle for injection, labeled as Outer Needle Shield, Inner Needle Shield, Needle, and Paper Tab. The diagram also depicts a separate Dose Knob used for adjusting dosage, shown as a blue ridged circular component.*
Figure (Lyumjev U100 Tp Ifu F4 V1)
An instructional diagram showing a close-up of a dose measurement window marked with units and numbers, alongside a blue adjustment knob with a red arrow pointing upward, suggesting dose setting or adjustment on an insulin pen device.*
Figure (Lyumjev U100 Tp Ifu F5 V1)
An instructional illustration showing a hand holding a vial of LYUMJEV insulin lispro-aabc injection solution vertically with an arrow pointing upward. A magnified inset highlights a drop at the vial's rubber stopper, indicating a step in preparation or use.*
Figure (Lyumjev U100 Tp Ifu F6 V1)
An instructional illustration showing a close-up view of a dose selector mechanism on a LYUMJEV insulin lispro-aabc injection pen, featuring a numbered dosage indicator and a blue dial or cap used for adjusting the dose.*
Figure (Lyumjev U100 Tp Ifu F7 V1)
An instructional diagram showing a close-up of a hand adjusting a medication pen dose selector. A red arrow indicates the direction to turn a blue dial to set the dosage. The dose window displays numbers 6, 8, and 10, representing dosage units.*
Figure (Lyumjev U100 Tp Ifu F8 V1)
An instructional illustration showing a close-up view of a syringe's dosage window, indicating the measurement scale between 10 and 12 units. A red arrow points specifically to the 11-unit mark on the dose indicator.*
Figure (Lyumjev U100 Tp Ifu F9 V1)
A diagram showing a close-up view of an insulin pen dose selector window with a red arrow pointing to the number 24. The pen dial has dose markings ranging from 2 to 8 units, highlighting adjustable dosage settings for insulin delivery.*
Package Label – Lyumjev U100 Tempo Pen 5 Count Carton (Lyumjev U100 Tpen Nl112 00)
LYUMJEV Tempo Pen (insulin lispro-aabc) injection, 100 units per mL (U-100), packaged as 5 x 3 mL prefilled pens. This product is labeled for single patient use only, intended for subcutaneous use, and requires prescription. The label indicates Eli Lilly and Company as the manufacturer and instructs dispensing in the sealed carton. It also includes storage, dosage, ingredient, and contact information.*
Package Label – Lyumjev U100 Vial Carton (Lyumjev U100 Vial 044 00)
Packaging label for LYUMJEV (insulin lispro-aabc) injection, 100 units per mL (U-100) in a 10 mL multiple-dose vial. The label indicates it is for subcutaneous or intravenous use and is Rx only. Manufactured by Eli Lilly and Company, the label includes storage instructions, a barcode, and contact information.*
Figure (Lyumjev U100 Vial Ifu F1 V1)
LYUMJEV injection, solution vial containing insulin lispro-aabc at 100 units per mL (U-100) concentration. The vial has a protective black cap over a visible rubber stopper. It is labeled for subcutaneous or intravenous use, multiple-dose vial by Eli Lilly and Company.*
Figure (Lyumjev U100 Vial Ifu F10 V1)
An instructional illustration showing a hand withdrawing liquid from a vial into a syringe. The syringe's volume markings are visible, highlighting the area between 10 and 40 units. An upward arrow indicates the direction of pulling the plunger to draw the medication into the syringe.*
Figure (Lyumjev U100 Vial Ifu F11 V1)
An instructional illustration showing a hand drawing liquid from a vial into a syringe. The syringe is held with the needle pointing upwards and a finger pressing the plunger, with an arrow indicating movement of the plunger to draw the solution into the syringe.*
Figure (Lyumjev U100 Vial Ifu F12 V1)
An anatomical illustration showing recommended injection sites on a human body for subcutaneous administration. Shaded areas include the abdomen, outer thighs, upper arms, and buttocks on both front and back views of the body.*
Figure (Lyumjev U100 Vial Ifu F13 V1)
An instructional line drawing showing a person injecting a solution into the abdomen. One hand pinches the skin while the other holds a syringe preparing for subcutaneous injection. An arrow indicates the direction of injection into the skin.*
Figure (Lyumjev U100 Vial Ifu F14 V1)
An instructional diagram showing a person receiving a subcutaneous injection in the neck area using a syringe, demonstrating the administration technique for the LYUMJEV insulin lispro-aabc injection solution.*
Figure (Lyumjev U100 Vial Ifu F15 V1)
An instructional illustration showing a hand administering an injection with a syringe into the abdomen. The diagram emphasizes correct injection technique for a subcutaneous route, focusing on proper positioning of the syringe and injection site.*
Figure (Lyumjev U100 Vial Ifu F2 V1)
An instructional diagram of an insulin syringe showing labeled parts: needle shield, needle, plunger tip, syringe body, and plunger. The syringe is marked with unit measurements from 0 to 100, with a close-up highlighting an example dose of 20 units at the plunger tip.*
Figure (Lyumjev U100 Vial Ifu F3 V1)
An instructional illustration showing a hand holding an injection vial with the cap being removed by peeling it upwards with the other hand. The image likely demonstrates the first step in preparing LYUMJEV injection solution for use.*
Figure (Lyumjev U100 Vial Ifu F4 V1)
An instructional illustration showing a hand holding a vial and using the other hand to remove a protective cap from the vial's top. The image is intended to depict the proper method to access the vial contents, relevant to injection preparation.*
Figure (Lyumjev U100 Vial Ifu F5 V1)
An instructional illustration showing a hand preparing an injection by drawing medication into a syringe. The inset zooms in on the syringe barrel, highlighting the volume markings from 10 to 40 units. The image demonstrates the technique for measurement and preparation of the subcutaneous or intravenous injection solution.*
Figure (Lyumjev U100 Vial Ifu F6 V1)
An instructional diagram showing a person drawing solution from a vial into a syringe, indicated by an arrow directing the syringe needle into the vial.*
Figure (Lyumjev U100 Vial Ifu F7 V1)
An instructional diagram showing hands inserting a needle into a vial or cartridge, indicating the proper technique for drawing up a dose of LYUMJEV insulin lispro-aabc injection solution for subcutaneous or intravenous administration.*
Figure (Lyumjev U100 Vial Ifu F8 V1)
An instructional illustration showing a hand holding a vial while drawing medication into a syringe. The syringe is marked with measurement lines up to 40 units, and a downward arrow indicates the motion of drawing the solution from the vial into the syringe.*
Figure (Lyumjev U100 Vial Ifu F9 V1)
An instructional illustration showing two hands preparing an injection. One hand holds a vial upside down, while the other hand holds a syringe being filled with solution from the vial, demonstrating proper medication drawing technique.*
Package Label – Lyumjev U200 Kwikpen 5 Count Carton (Lyumjev U200 Kp 054 00)
LYUMJEV KwikPen (insulin lispro-aabc) injection, 200 units per mL (U-200), in a package containing 2 x 3 mL prefilled pens. The label indicates the product is for subcutaneous use only and requires a prescription. The packaging also includes warnings about not transferring to a syringe to avoid overdose, and states needles are not included. The product is labeled with the manufacturer Eli Lilly and Company and includes storage instructions, dosing reference, and contact information.*
Figure (Lyumjev U200 Kp Ifu F1 V1)
LYUMJEV KwikPen injection pen for insulin lispro-aabc, clearly labeled for single patient use with a concentration of 200 units per mL (U-200). The pen includes a dosage dial visible at the end. The labeler is Eli Lilly and Company.*
Figure (Lyumjev U200 Kp Ifu F10 V1)
LYUMJEV 100 units/mL injection, solution, human prescription drug by Eli Lilly and Company. The image shows a portion of the vial cap and neck with a white label featuring a partial numeric scale, indicating dosage measurement increments.*
Figure (Lyumjev U200 Kp Ifu F11 V1)
An illustration showing a close-up of a hand pulling a tab or strip upward, indicated by a red arrow pointing up, suggesting an action to open or peel a part of the packaging or device.*
Figure (Lyumjev U200 Kp Ifu F12 V1)
An instructional diagram showing a close-up view of a portion of a vial label, highlighting the presence of a numeric value, likely indicating dosage strength or volume, with an arrow pointing to the area on the label. The diagram simplifies the vial label to emphasize this specific part for identification or verification purposes.*
Figure (Lyumjev U200 Kp Ifu F13 V1)
An illustration showing a close-up view of the dose window on an injection pen for LYUMJEV insulin lispro-aabc. The dose indicator displays numbers with a red arrow pointing between 24 and 26 units, demonstrating dose selection on the pen.*
Figure (Lyumjev U200 Kp Ifu F14 V1)
Illustration showing a hand administering an injection into the abdomen, demonstrating subcutaneous injection technique likely related to LYUMJEV insulin lispro-aabc injection.*
Figure (Lyumjev U200 Kp Ifu F15 V1)
LYUMJEV 100 units per mL injection solution vial, a human prescription drug containing insulin lispro-aabc. The image shows a portion of the vial with measurement markings and a gray cap, labeled by Eli Lilly and Company.*
Figure (Lyumjev U200 Kp Ifu F16 V1)
Instructional illustration showing a hand removing the cap from a prefilled pen injector, likely for LYUMJEV insulin lispro-aabc injection. The diagram emphasizes the step of detaching the needle cap before use.*
Figure (Lyumjev U200 Kp Ifu F17 V1)
An instructional illustration showing a hand holding an insulin injection pen labeled LYUMJEV. The pen is encircled by a red arrow indicating a twisting or turning motion, suggesting how to prepare or use the pen for injection.*
Figure (Lyumjev U200 Kp Ifu F18 V1)
An illustration showing the removal of a cap clip from a pen-shaped injection device for LYUMJEV (insulin lispro-aabc) injection solution. The image indicates the direction to slide or pull the cap clip off the device, with a labeled pointer identifying the cap clip component.*
Figure (Lyumjev U200 Kp Ifu F2 V1)
A warning label panel displaying a yellow background with a black exclamation point in a triangle. The text reads: 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT.' This label cautions against transferring the medication to a syringe due to overdose risk.*
Figure (Lyumjev U200 Kp Ifu F3 V1)
An instructional diagram illustrating the parts of the LYUMJEV KwikPen and the pen needle components. It labels the pen cap, cap clip, cartridge holder, rubber seal, plunger, label, pen body, dose indicator, dose window, and dose knob. Additionally, it shows pen needle parts including the outer needle shield, inner needle shield, needle, and paper tab, with the dose knob shown separately.*
Figure (Lyumjev U200 Kp Ifu F4 V1)
An instructional illustration showing the removal of a gray needle cap from a syringe or pen injector. A red arrow points leftward indicating the direction to pull the cap off. The connected device includes a visible yellow label on the right end.*
Figure (Lyumjev U200 Kp Ifu F5 V1)
An instructional illustration showing a tube with a red arrow indicating the direction to unwrap or remove a protective seal or cap from the nozzle end of the product. No text or branding details are visible in the image.*
Figure (Lyumjev U200 Kp Ifu F6 V1)
An instructional illustration showing that the cap of a syringe or injection device should be kept, while the needle part is to be thrown away. The image uses simple line drawings with a red arrow pointing to the cap and labels indicating proper disposal instructions.*
Figure (Lyumjev U200 Kp Ifu F7 V1)
An illustration showing a dosage scale on a medication syringe or pen injector, marked with units 1 and 2, and a red arrow indicating upward adjustment of the dose.*
Figure (Lyumjev U200 Kp Ifu F8 V1)
An instructional illustration showing a hand holding a syringe prefilled with LYUMJEV (insulin lispro-aabc) injection, solution. The image depicts the process of preparing the injection, highlighting a hand tapping the syringe to remove air bubbles before administration.*
Figure (Lyumjev U200 Kp Ifu F9 V1)
An instructional illustration showing how to prepare a syringe for injection. It depicts a hand holding a syringe with the thumb pushing upward on the plunger. A magnified inset highlights a drop of liquid at the needle tip, indicating the expulsion of air bubbles before injection.*
Insulin Lispro-aabc Primary Structure (Lyumjev Uspi Chem V1)
Chemical structure diagram showing the amino acid sequence and disulfide bonds of insulin lispro-aabc's A-Chain and B-Chain. Amino acid residues are represented as black circles labeled with their respective abbreviations and positions.*
Figure 1 (Lyumjev Uspi F1 V1)
Line graph depicting the insulin effect (GIR: mg/kg/min) over time (hours) for LYUMJEV at doses of 7U, 15U, and 30U. The graph shows insulin effect rising quickly, peaking around 1.5-2 hours, and then gradually declining up to 7 hours, with higher doses producing greater effect.*
Figure 2 (Lyumjev Uspi F2 V1)
A line graph showing the mean serum insulin lispro concentration (pmol/L) of LYUMJEV over time (hours). The concentration rises sharply to around 550 pmol/L at approximately 1 hour, then gradually declines over the next several hours, approaching near zero by 6 hours.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
